Skip to main content
Fig. 1 | BMC Medicine

Fig. 1

From: The citrate transporter SLC13A5 as a therapeutic target for kidney disease: evidence from Mendelian randomization to inform drug development

Fig. 1

Overview of the study design. BUN: blood urea nitrogen, CRP:C-reactive protein, CKD: chronic kidney disease; eGFR: estimated glomerular filtration rate, HDLc: high-density lipoprotein cholesterol, IL6: interleukin 6; LDLc: low-density lipoprotein cholesterol, SNP: single-nucleotide polymorphism, uACR: urine albumin-creatinine ratio

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us